Italy bans Novartis flu vaccine after suspicious deaths
Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday amid fears it may have caused three deaths.
Nov 27, 2014
0
0
Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday amid fears it may have caused three deaths.
Nov 27, 2014
0
0
Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.
Oct 27, 2014
0
0
The European Union's antitrust authority says it has approved the $5.4 billion sale of Novartis' animal health division to U.S. pharmaceutical firm Eli Lilly.
Oct 3, 2014
0
0
The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.
Sep 1, 2014
0
0
Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis.
Aug 20, 2014
0
0
Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.
Jul 17, 2014
0
0
Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.
Jul 15, 2014
0
0
Japanese prosecutors Tuesday laid charges against the local unit of Swiss pharmaceutical giant Novartis in a widening scandal over claims that falsified data were used to exaggerate the benefits of a popular blood-pressure ...
Jul 1, 2014
0
0
Italy's health ministry is seeking 1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported ...
May 28, 2014
0
0
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0